/
results.html
553 lines (412 loc) · 34.3 KB
/
results.html
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Results</title>
<link rel="stylesheet" type="text/css" href="css/nav.css">
<link rel="stylesheet" type="text/css" href="./css/new1.css">
<link rel="stylesheet" type="text/css" href="css/painter.css">
<link rel="stylesheet" type="text/css" href="./css/page/results_painter.css">
<link rel="stylesheet" type="text/css" href="./css/page/results.css">
<script src="https://ajax.aspnetcdn.com/ajax/jquery/jquery-3.5.1.min.js"></script>
<script>
window.addEventListener('scroll', function() {
let top = window.scrollY
console.log(top)
if (top > 200) {
$('.main').css('transform', 'translateY(-300px)')
} else {
$('.main').css('transform', 'translateY(0%)')
}
})
</script>
</head>
<body>
<div id="loading">
<div class='loadingX' style="background-color: #abc2ea;">
<img src="./image/lodding_3.gif" height=100% width=100%>
</div>
</div>
<script>
document.onreadystatechange = function() {
if (document.readyState === "complete") {
setTimeout(
function() {
// document.querySelector("#loading").style.opacity = "0%";
document.querySelector("#loading").style.display = "none";
document.querySelector("#globalWrapper").style.display = "block";
}, 3000)
}
}
</script>
<div id='globalWrapper'>
<div id="content" role="main" style="background-color: white">
<div id="HQ_page">
<section class="menu-section-area">
<!-- Navigation -->
<nav class="menu">
<div style="height: 0px;width: 0px;position: relative;">
<img src="./image/logo.png" width="50px" height="50px" style="position:absolute;top:-14px;">
</div>
<ol>
<li class="menu-item"><a href="./index.html">Home</a></li>
<li class="menu-item">
<a href="#0">Project
<svg version="1.1" class="plus-icon" xmlns="http://www.w3.org/2000/svg"
xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 18 18">
<line fill="none" stroke-width="4" stroke-linecap="round" stroke-miterlimit="10"
x1="10" y1="9" x2="17" y2="9" />
<line fill="none" stroke-width="4" stroke-linecap="round" stroke-miterlimit="10"
x1="9" y1="9" x2="9" y2="1" />
<g id="lineGroup_1">
<line fill="none" stroke-width="4" stroke-linecap="round"
stroke-miterlimit="10" x1="1" y1="9" x2="8" y2="9" />
<line fill="none" stroke-width="4" stroke-linecap="round"
stroke-miterlimit="10" x1="9" y1="17" x2="9" y2="9" />
</g>
</svg>
</a>
<ol class="sub-menu">
<li class="sub-menu-item"><a href="./description.html">Description</a></li>
<li class="sub-menu-item"><a href="./design.html">Design</a></li>
<li class="sub-menu-item"><a href="./results.html">Results</a></li>
<li class="sub-menu-item"><a href="./supplement.html">Supplement</a></li>
<li class="sub-menu-item"><a href="./protocol.html">Protocol</a></li>
</ol>
</li>
<li class="menu-item"><a href="./lab_notebook.html">Lab notebook</a></li>
<li class="menu-item">
<a href="#0">Team
<svg version="1.1" class="plus-icon" xmlns="http://www.w3.org/2000/svg"
xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 18 18">
<line fill="none" stroke-width="4" stroke-linecap="round" stroke-miterlimit="10"
x1="10" y1="9" x2="17" y2="9" />
<line fill="none" stroke-width="4" stroke-linecap="round" stroke-miterlimit="10"
x1="9" y1="9" x2="9" y2="1" />
<g id="lineGroup_1">
<line fill="none" stroke-width="4" stroke-linecap="round"
stroke-miterlimit="10" x1="1" y1="9" x2="8" y2="9" />
<line fill="none" stroke-width="4" stroke-linecap="round"
stroke-miterlimit="10" x1="9" y1="17" x2="9" y2="9" />
</g>
</svg>
</a>
<ol class="sub-menu">
<li class="sub-menu-item"><a href="./team.html">Team</a></li>
<li class="sub-menu-item"><a href="./collaboration.html">Collaboration</a></li>
</ol>
</li>
</nav>
<!-- Navigation -->
</section>
<div class="img1"></div>
<div class="lnav">
<ul class="navul" style="margin-left: 0;padding: 0;">
<li id="nav1" class="uli cntli" style="height: 60px;line-height: 1.5em;">
<a href="#p1">Bioinformatics Analysis</a>
</li>
<li id="nav2" class="uli cntli" style="height: 60px;line-height: 1.5em;">
<a href="#p2">Screening by Fluorescence</a>
</li>
<li id="nav3" class="uli cntli" style="height: 50px;">
<a href="#p3">PACE</a>
</li>
<!-- <li id="nav4" class="uli cntli">
<a href="#p5">Note</a>
</li> -->
<li id="nav4" class="uli cntli" style="height: 50px;">
<a href="#p4">Reference</a>
</li>
</ul>
</div>
<div class="content">
<div class="main" style="color: black;word-wrap: break-word;word-break: normal;">
<aside>
<div class="p1" id="p1">
</br>
<h1 style="text-align:left;font-size: 25px;line-height: 30px; ">Bioinformatics Analysis
</h1>
<p style="text-indent:2em;">Four mutational residues (Y32L, A67S, H70N, A167Q) were introduced to Gen 2 and the mutant was named "Mutpre" (mutant prediction). The structures of Gen 2 and Mutpre predicted by AlphaFold2 were aligned and the consequent
RMSD (Root Mean Square Deviation) was 2. 01, which means they shared similar structures (RMSD
< 3). Analysis of the four mutational residues indicates that they are closed to each other in tertiary structure, though not continuous in primary structure. The four residues formed a pocket together, among which the Y32 itself is a binding site of
tyrosine. The molecular dynamic simulation of the two proteins shows that, Mutpre seems to be less stable than Gen 2 (the former has larger RMSD). Mutpre and Gen 2 shared a similar level of compactness, for they shared
similar fluctuating range of Rg, radius of gyration. Most importantly, four mutational residues increased the flexibility of Mutpre compared to Gen 2 globally, indicated by RMSF (Root Mean Square Fluctuation). The flexibility
of some local regions are also significantly increased. The increase of global and local flexibility may indicate higher catalytic activity. </p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-1.jpg" width="600px" height="400px" style="">
</div>
</br>
<p><b>Figure 1. Results of modeling and MD simulation. (a) </b>Alignment of Gen 2 and Mutpre. The grey structure shows Gen 2 and the pink structure shows Mutpre. Y32, A67, H70, A167 in Gen 2 were emphasized by red
sticks and balls, while 32Y, 67A, 70H, 167A in Mutpre were by grey. (b) RMSD of Gen 2 and Mutpre during 1 ns simulation. (c) Radius of gyration of Gen2 and Mutpre during 1 ns simulation. (d) RMSF of Gen 2 and
Mutpre per residue. </p>
</div>
</br>
</br>
<div class="p2" style="" id="p2">
<h1 style="text-align:left;font-size: 25px;line-height: 30px; ">Screening by Fluorescence
</h1>
<p style="text-indent:2em;">Mutation libraries were constructed by error-prone PCR and site-directed mutagenesis. To determine the optimal conditions of error-prone PCR, a series of annealing temperature gradients and StarMut Enhancer gradients were
set, and the optimal error-prone reaction system was determined based on the results of agarose gel electrophoresis. The final error-prone PCR conditions used were 53. 1℃ (annealing temperature) and 6 μL enhancer. </p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-2.png" width="500px" height="400px" style="">
</div>
</br>
<p><b>Figure 2. Pre-experiments to explore best error-prone PCR condition. </b>Set the StarMut Enhancer volume gradients for error-prone PCR, the enhancer volumes were 2μL, 4μL and 6μL in order. 6μL enhancer in 20 µL system
with appropriate mutation rate was finally chosen.
</p>
<p style="text-indent:2em;">
The mutated fragment was homologously recombined with the linearized vector p15A-pBAD, and transferred into C321 ΔA muts-T7. The mutation rate is 3-18 mutant bases per kb. Currently, the library constructed by error-prone PCR has contained approximately
1. 5 × 10<sup>4</sup> mutants.
</p>
<p style="text-indent:2em;">
Four amino acid mutation sites were predicted based on Hotspot Wizard software: Y32, A67, A70 and A167. We designed three pairs of IUB code-containing degenerate primers and used Gen 2 as a template to construct the library. The library constructed by
site-directed mutation has contained approximately 500 mutants.
</p>
<p style="text-indent:2em;">
A screening platform that measures the degree of incorporation of L-DOPA was established, and we quantified its efficiency and specificity. TyrRS specifically recognizes tyrosine and catalyzes the formation of tyrosyl-tRNA. To avoid affecting the normal
function of the original TyrRS in cells, we applied the modified TyrRS to the orthogonal translation system. This modified TyrRS catalyzes the aminoacylation of an artificial tRNA whose anticodon is UAG. Therefore,
<i>E. coli</i> C321 ΔA muts-T7 strain was chosen as the host, in whose genome the UAG codons have been replaced by other stop codon, in order to avoid the incorporation of Tyr in UAG anticodon. The orthogonal TyrRS
and modified strain enable the incorporation of noncanonical amino acids without interfering with the normal growth of <i>E. coli</i>.
</p>
<p style="text-indent:2em;">
In order to select aaRS variants with potential capability of L-DOPA incorporation, sfGFP Y66-S205C containing the L-DOPA incorporation was applied as a reporter. It can emit green fluorescence (absorption peak at Ex=450 nm/Em=500 nm) with residue Y66
while emitting orange fluorescence (absorption peak at Ex=535 nm/Em=585 nm) with residue DOPA66 . The intensity of orange fluorescence is positively proportional to the increase of L-DOPA incorporation. Thereby aaRS
variants’ specificity and activity of binding L-DOPA could be quantified.
</p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-3.jpg" width="650px" height="350px" style="">
</div>
</br>
<p style="">
<b>Figure 3. (a) </b>After incubation with inducer for 8 hours, we resuspended the culture of transformants and plotted the emitted fluorescence intensity (Ex = 440-560 nm). (b) Emission spectrum of culture of transformants
(Ex = 450 nm). The emission peak is around 500 nm. (c) Emission spectrum of culture of transformants (Ex = 535 nm). The emission peak is around 585 nm.
</p>
<p style="text-indent:2em;">
To ensure that sfGFP could be expressed with the existence of aaRS, Gen 2 operated by the arabinose promoter was integrated into the pET28a vector; sfgfp operated by the IPTG operon was integrated into the pBAD33 vector. The two plasmids mentioned above
were transformed into C321 ΔA muts-T7 to build a complete pathway.
</p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-5.png" width="350px" height="260px" style="">
</div>
</br>
<p style="">
<b>Figure. 4 </b>The map of sfGFP Y66-S205C. This plasmid contains the sfGFP-Y66DOPA-S205C sequence and the IPTG operon used to manipulate it.
</p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-4.jpg" width="320px" height="250px" style="">
</div>
</br>
<p style="">
<b>Figure. 5 </b>The map of p15A-PBAD-Gen2-tRNACUA opt. This plasmid contains the MjTYR-Gen2 sequence and the arabinose promoter used to manipulate it, as well as the modified tRNA(with UAG anticode) sequence used to
express substrate for aminoacylation reactions.
</p>
<p style="text-indent:2em;">
Pre-experiments were conducted to determine a stable induction culture protocol by setting different culture conditions, such as L-DOPA concentration, media type, presence or absence of chloramphenicol, etc. When DOPA concentration was 0. 78 mM/L and
chloramphenicol was present, the leakiness on the lac operon and arabinose promoter was relatively low. To obtain intensive fluorescence, the DOPA is induced to incorporate into sfGFP with the culturing of LBL and DAM
medium. Finally, we applied 0. 78 mM/L L-DOPA, LBL and DAM medium to obtain low leakage expression and the intensive fluorescence level.
</p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-6.png" width="620px" height="550px" style="">
</div>
</br>
<p style="text-indent:0em;">
<b>Figure 6. (a) </b>Three control groups were set: no induction, only arabinose, only IPTG. The experimental group was added with both Ara and IPTG. The base concentration of L-DOPA was 0. 52 mM/L, on which we diluted
to 0. 8-10 times. We found that 1-4 times of L-DOPA worked better, and 2 times of L-DOPA acted best. (b) The control groups were added to all inducers separately without DAM, and the experimental group was added to
DAM. The Mean Fluorescence Intensity (MFI)/OD<sub>600</sub> of the experimental group was about 2 times about that of the control groups.
</p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-7.png" width="670px" height="400px" style="">
</div>
</br>
<p style="">
<b>Figure 7. </b>Overview of mutation, selection and characterization strategy in this study. Gen 2 was mutated by error-prone PCR and site-directed mutagenesis. We use homologous recombination to construct mutation
library. Mutants were then selected by fluorescence with plate reader.
</p>
<p style="text-indent:2em;">
Our mutation library contains about 1. 5×10<sup>4</sup> positive transformants in total. The single clones were cultured, induced, and measured 30 variants were screened by fluorescence assay. We measure the fluorescence
after induced expression of fluorescent protein to screen out mutant strains with high orange MFI. In general, the fluorescence intensity is positively correlated with the reproduction of the strains (the expression
amount of sfGFP) and the L-DOPA incorporation efficiency. However, considering the influence of background fluorescence intensity on instrument detection, we usually consider data with low OD<sub>600</sub> to be unreliable.
Therefore, the variants with high MFI/OD<sub>600</sub> but too low OD<sub>600</sub> will be firstly eliminated.
</p>
</br>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results-8.png" width="500px" height="300px" style="">
</div>
</br>
<p style="">
<b>Figure. 8 </b>Heatmap of partial mutation library. Variants mutated by error-prone PCR or site-directed mutagenesis (SDM) were labled on the raw title. Mutatants with high MFI/OD<sub>600</sub> but too low OD<sub>600</sub> were gray and placed "X" through on.
</p>
<p style="text-indent:2em;">
The variants MFI/OD<sub>600</sub> was higher than that of the control group, and the colony reproduction was at a reasonable level (1. 0
< OD<sub>600</sub>
< 1. 4). Statistically, it was found that the MFI / OD<sub>600</sub> of these variants was concentrated in the range of 1. 2-2. 0 times that of the control group. They are considered benign mutants to bind L-DOPA strongly. These variants were sequenced to further explore
the exact mutation points. So far, we have not obtained the final sequencing data. In the future, the necessary analysis to this section will be added. </p>
</div>
<div class="p3" id="p3">
</br>
<h1 style="text-align:left;font-size: 25px;line-height: 30px; ">Phage-assisted
<br />Continuous Evolution (PACE)</h1>
<p style="text-indent:2em;">Currently, we have successfully constructed the plasmids (SP, AP and CP) required for PACE.
</br>
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results/r-1.jpg" width="300px" height="230px" style="">
</div>
</br>
<p><b>Figure 9. The map of selection phage (SP). </b>The SP plasmid is based on the M13 wild-type phage with the
<I>gⅢ</I> removed, plus the tyrosine aminoacyl tRNA synthetase to be mutated and an artificial RBS sequence.
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results/r-2.jpg" width="350px" height="300px" style="">
</div>
</br>
<p><b>
Figure 10. The map of accessory plasmid (AP).
</b>The AP plasmid includes a tRNA sequence that recognises the TAG codon and the
<i>gⅢ</i> and LuxAB genes controlled by the T7 promoter.
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results/r-3.png" width="320px" height="260px" style="">
</div>
</br>
<p><b>
Figure 11. The map of complementary plasmid (CP).
</b>The CP plasmid contains the T7 RNAP, which contains two amber termination mutations.
</p>
<p>
All plasmids constructed are verified by sequencing. In addition, we validated the SP by virus plaque formation and validated the AP by luciferase characterization.
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results/ab.jpg" width="800px" height="400px" style="">
</div>
</br>
<p><b>
Figure 12. Previous results of PACE. (a)
</b>Wild-type M13 phage; from the upper right quadrant, upper left quadrant, lower right quadrant, and lower left quadrant, the phage concentrations are 100, 10-2, 10-4, 10-6 in order, and the number of phages in appropriate
in quadrants can be used to quantify the titer. (b) Luciferase characterization. TyrRS ligates L-DOPA to the amber repressor tRNA, enabling complete translation of T7 RNAP and access to the protein structure. T7 RNAP
production activates the T7 promoter, leading to the expression of the downstream luciferase. That is, it can be used to monitor the intensity of <i>gⅢ</i> expression, whether the lines are coupled, and the amount of
amber repressor introduced in T7 RNAP.
</p>
<p style="text-indent:2em;">The PACE device is partially based on the work of Liu and co-workers
<sup>1</sup>. Due to the differences in industrial product standards between the US and China, we have built the complete device using partially functionally identical Chinese made equipment.
</p>
<p style="text-indent:2em;">
The tubing used in the device and its matching Luer fittings and other accessories were all from Baoding Longer Precision Pump Company Co., Ltd. The two peristaltic pumps used were the BT100M model from Baoding Chuang Rui Precision Pump Co., Ltd. with
the DG-N model pump head. And the two syringe pumps were the LD-P2020II model from Shanghai Lande Medical Devices Co.,Ltd. The rest of the small parts were sourced from Taobao.
</p>
<p style="text-indent:2em;">Once the equipment and materials were available, we assembled and commissioned the device and confirmed that the whole system was operational. Two peristaltic pumps controlled the inflow and outflow of media from the chemostat,
and the inflow and outflow of waste from the chemostat cell culture in the lagoons. And two syringe pumps controlled the injection of arabinose solution into the two lagoons. The apparatus are shown below.
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results/r-5.jpg" width="500px" height="300px" style="">
</div>
</br>
<p><b>Figure 13. Photo of our PACE apparatus.</b> The devices from left to right are Peristaltic Pump 1, Chemostat, Peristaltic Pump 2, Lagoons 1 and 2, and Syringe Pumps 1 and 2. The medium flows continuously throughout the
system through the bucket at the rear. During the experiment, the parts other than the electronics will be placed in an incubator at around 37°C.
</p>
<p style="text-indent:2em;">
In the meantime, we used the <i>E.coli</i> S2208 to validate the chemostat’s function and enable it to output a constant fluid with the absorbance (OD<sub>600</sub>) of ~0.6 for 16 hours.
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<img src="./image/results/r-6.png" width="900px" height="400px" style="">
</div>
</br>
<p><b>
Figure 14. Dynamic changes in the absorbance of the culture liquid during the
commissioning process.
</b> In order to make it easier to monitor the operating status of the chemostat after the device is in stable operation, we have designed an Arduino-based device for the real-time determination of the 600 nm absorbance
of the bacterial solution in the chemostat, taking into account the work of Lin<sup>2</sup>. The device measures the absorption of 940 nm light-emitting diode light by the bacterial solution and converts it to an approximate
value of OD<sub>600</sub> against a calibration curve determined in advance, thus providing information for the working state of the chemostat.
</p>
<div style="display: flex;justify-content: center;align-items: center;">
<video src="./image/results/lod.mp4" controls="controls" loop="loop" style="width: 400px;" muted autoplay></video>
</div>
</br>
<p><b>
Figure 15. The device we designed for measuring absorbance. </b> We had encountered great difficulties in the SP plasmid construction part due to lack of experience. Now we are happy to see that the system is taking
shape. However, we still have some work to do before the PACE system is officially running. We will continue to experiment and make efforts for more progress in the future.
</p>
<p style="text-indent:2em;">Source Code of the device for measuring absorbance is available in <a href="https://github.com/Station724/real-time_determination_of_the-_absorbance">GitHub</a>.
</br>
</p>
</div>
<div class="p4" id="p4">
</br>
<h1 style="text-align:left;font-size: 25px;line-height: 30px; ">Reference</h1>
<p>1 S. M. Miller, T. Wang, D. R. Liu, Phage-assisted continuous and non-continuous evolution. Nature Protocols 15, 4101-4127 (2020). <br /> https://10.1038/s41596-020-00410-3
</p>
<P> 2 D.-S. Lin, C.-H. Lee, Y.-T. Yang, Wireless bioreactor for anaerobic cultivation of bacteria. Biotechnology Progress 36, (2020). <br /> https://10.1002/btpr.3009
</p>
</div>
</br>
</br>
</aside>
</div>
</div>
</div>
</div>
<div class="footer " style="position:absolute;right:0;left:0;margin:0 auto;width: 100%;height: 400px;background-color: black;margin-top: -200px;position: relative;">
<div class="container" style="width:100%;height:100%;background-color: black;width: 100%;font-size: 14px;">
<div class="footer-img" style="position:absolute;left: 0;">
<img src="./image/footer.jpg" width="600px" height="230px">
</div>
<div class="footer-content" style="text-align: center;right: 0;height: 100%;width: 50%;background-color: black;top: 0;">
<ul class="footer-content-ul">
<li class="first">
<a href="./index.html" style="font-size: 21px;">HOME</a>
</li>
</ul>
<ul>
<li class="first">
<a href="./description.html" style="font-size: 21px;">PROJECT</a>
</li>
<li>
<a href="./description.html">Description</a>
</li>
<li>
<a href="./design.html">Design</a>
</li>
<li>
<a href="./results.html">Results</a>
</li>
<li>
<a href="./supplement.html">Supplement</a>
</li>
<li>
<a href="./protocol.html">Protocol</a>
</li>
</ul>
<ul class="footer-content-ul">
<li class="first">
<a href="./lab_notebook.html" style="font-size: 18px;">LAB NOTEBOOK</a>
</li>
</ul>
<ul class="footer-content-ul">
<li class="first">
<a href="./team.html" style="font-size: 21px;">TEAM</a>
</li>
<li>
<a href="./team.html">Team</a>
</li>
<li>
<a href="./collaboration.html">Collaboration</a>
</li>
</ul>
</div>
<div class="footer-row">
<div class="col-md-12 " style="margin-top: -30px; ">
<p style="text-align: center;font-size: 16px; color: white;">Copyright © 2022 NAU All rights reserved.
</p>
</div>
</div>
</div>
</div>
<script src="./js/longli.js"></script>
</html>